Skip to main content
Explore URMC
menu

Charles Venuto, Pharm.D.

Publications

Showing all 19 journal articles & 0 books available

Journal Articles

2020
Talal AH, Ding Y, Venuto CS, Chakan LM, McLeod A, Dharia A, Morse GD, Brown LS, Markatou M, Kharasch ED. "Toward precision prescribing for methadone: Determinants of methadone deposition." PloS one.. 2020 15(4):e0231467. Epub 2020 Apr 17.

11/2017
Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS. "Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation." The Lancet. Neurology.. 2017 Nov 0; 16(11):908-916. Epub 2017 Sep 25.

7/1/2017
Gupta SK, Yeh E, Kitch DW, Brown TT, Venuto CS, Morse GD, Ha B, Melbourne K, McComsey GA. "Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s." The Journal of antimicrobial chemotherapy.. 2017 Jul 1; 72(7):2042-2048.

5/2017
Venuto CS, Markatou M, Woolwine-Cunningham Y, Furlage R, Ocque AJ, DiFrancesco R, Dumas EO, Wallace PK, Morse GD, Talal AH. "Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques." Antimicrobial agents and chemotherapy.. 2017 May 0; 61(5)Epub 2017 Apr 24.

3/2017
Venuto CS, Talal AH. "Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology." Clinical pharmacology in drug development. 2017 Mar 0; 6(2):169-175.

3/2017
Talal AH, Venuto CS, Younis I. "Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment." Clinical pharmacology in drug development. 2017 Mar 0; 6(2):206-212.

3/2017
Bednasz CJ, Venuto CS, Ma Q, Morse GD. "Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications." Clinical pharmacology in drug development. 2017 Mar 0; 6(2):135-139.

7/2016
Venuto CS, Potter NB, Ray Dorsey E, Kieburtz K. "A review of disease progression models of Parkinson's disease and applications in clinical trials." Movement disorders : official journal of the Movement Disorder Society.. 2016 Jul 0; 31(7):947-956. Epub 2016 May 26.

3/2016
Rowe IA, Tully DC, Armstrong MJ, Parker R, Guo K, Barton D, Morse GD, Venuto CS, Ogilvie CB, Hedegaard DL, McKelvy JF, Wong-Staal F, Allen TM, Balfe P, McKeating JA, Mutimer DJ. "Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.. 2016 Mar 0; 22(3):287-97.

2016
Bednasz C, Luque AE, Zingman BS, Fischl MA, Gripshover BM, Venuto CS, Gu J, Feng Z, DiFrancesco R, Morse GD, Ma Q. "Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders." Current vascular pharmacology.. 2016 14(3):280-7.

2015
Bednasz CJ, Sawyer JR, Martinez A, Rose PG, Sithole SS, Hamilton HR, Kaufman FS, Venuto CS, Ma Q, Talal A, Morse GD. "Recent advances in management of the HIV/HCV coinfected patient." Future virology.. 2015 10(8):981-997.

12/2014
Venuto CS, Mollan K, Ma Q, Daar ES, Sax PE, Fischl M, Collier AC, Smith KY, Tierney C, Morse GD. "Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202." The Journal of antimicrobial chemotherapy.. 2014 Dec 0; 69(12):3300-10. Epub 2014 Aug 25.

2/2014
Smith KY, Tierney C, Mollan K, Venuto CS, Budhathoki C, Ma Q, Morse GD, Sax P, Katzenstein D, Godfrey C, Fischl M, Daar ES, Collier AC, . "Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2014 Feb 0; 58(4):555-63. Epub 2013 Nov 18.

1/2012
Venuto CS, McGarry A, Ma Q, Kieburtz K. "Pharmacologic approaches to the treatment of Huntington's disease." Movement disorders : official journal of the Movement Disorder Society.. 2012 Jan 0; 27(1):31-41. Epub 2011 Oct 13.

1/2012
Kieburtz K, Venuto C. "TRACK-HD: both promise and disappointment." The Lancet. Neurology.. 2012 Jan 0; 11(1):24-5. Epub 2011 Dec 02.

6/2011
Ma Q, Zingman BS, Luque AE, Fischl MA, Gripshover BM, Venuto CS, DiFrancesco R, Forrest A, Morse GD. "Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders." Therapeutic drug monitoring.. 2011 Jun 0; 33(3):309-14.

4/12/2011
Goodman L, Sia C, Carnes R, Vetter L, Taubman F, Venuto CS, McGarry A, Kieburtz K, Agarwal P. "Advocacy Recruiting for Huntington's Disease Clinical Trials." PLoS currents.. 2011 Apr 12; 3:RRN1230. Epub 2011 Apr 12.

12/2010
Venuto C, Butler M, Ashley ED, Brown J. "Alternative therapies for Clostridium difficile infections." Pharmacotherapy.. 2010 Dec 0; 30(12):1266-78.

3/2007
Ma Q, Brazeau D, Zingman BS, Reichman RC, Fischl MA, Gripshover BM, Venuto CS, Slish JC, DiFrancesco R, Forrest A, Morse GD. "Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV." Pharmacogenomics.. 2007 Mar 0; 8(3):227-35.